#BEGIN_DRUGCARD DB02742

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
109944-15-2

# ChEBI_ID:
Not Available

# Chemical_Formula:
C8H12N2O6

# Chemical_IUPAC_Name:
(5R,6R,7S,8S,8aR)-6,7,8-trihydroxy-5-(hydroxymethyl)-octahydroimidazolidino[1,2-a]pyridine-2,3-dione

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Enzyme Inhibitors

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Kifunensine

# HET_ID:
KIF

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H12N2O6/c11-1-2-3(12)4(13)5(14)6-9-7(15)8(16)10(2)6/h2-6,11-14H,1H2,(H,9,15)/t2-,3-,4+,5-,6-/m1/s1

# InChI_Key:
InChIKey=OIURYJWYVIAOCW-VFUOTHLCSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2742

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
232.1907

# Molecular_Weight_Mono:
232.069536126

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1KRF

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.5

# Predicted_LogS:
-0.09

# Predicted_Water_Solubility:
1.90e+02 g/l

# Primary_Accession_No:
DB02742

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936476

# PubChem_Substance_ID:
46505714

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01973

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H]2NC(=O)C(=O)N12

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:26 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
D45839

# Drug_Target_1_GenBank_ID_Protein:
987684

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
MSDC

# Drug_Target_1_Gene_Sequence:
>1536 bp
ATGCGTCTTCCAGTGTCATTCCCTCTGACAGTTCTGAGCTTGTTGGGCTCGACAATTGCT
CATCCCTATGGCGAGACCGAGGCTGTTTTGCGAAGTGAGCCTAAGAGTAACCAAGCCAAA
GCCGACGCTGTCAAAGAGGCCTTCCAGCACGCGTGGAATGGATACATGAAATATGCCTTC
CCTCATGACGAGTTGACTCCTGTCAGCAATGGTCATGCCGACTCTAGAAATGGATGGGGG
GCCTCAGCAGTTGACGCGCTTTCCACGGCCGTGATTATGGGCAAAGCGGATGTTGTGAAT
GCCATTCTCGAGCATGTCGCCGACATTGACTTCTCGAAGACCTCGGATACCGTCAGTCTT
TTCGAAACAACCATTCGTTACTTGGCGGGTATGCTATCGGGTTACGATCTGCTTCAGGGA
CCTGCCAAGAATTTGGTCGATAACCAAGACCTCATTGACGGATTACTGGACCAGTCAAGA
AACCTGGCCGATGTTCTGAAATTTGCTTTCGATACCCCTTCGGGTGTCCCCTATAATAAC
ATCAACATCACCTCGCACGGAAATGACGGCGCAACCACTAATGGCCTCGCTGTGACTGGC
ACACTGGTTCTGGAATGGACTCGTCTTTCTGATCTGACAGGTGATGAAGAGTATGCCAAA
TTAAGCCAGAAGGCCGAGTCTTATCTGCTCAAGCCGCAGCCATCGAGCAGCGAGCCTTTC
CCTGGTCTCGTAGGCAGCTCGATTAATATCAACGATGGTCAATTTGCCGACTCCAGAGTC
TCTTGGAATGGAGGTGACGATTCATTCTATGAGTACCTGATCAAGATGTACGTGTACGAC
CCTAAGCGGTTTGAGACATACAAGGATCGCTGGGTCCTGGCAGCCGAGTCGACTATCAAG
CATCTCAAGTCGCACCCGAAGTCCCGCCCGGACTTGACGTTCCTGTCTTCCTACAGTAAC
AGGAATTATGATCTCAGCTCGCAGCACCTGACTTGCTTCGATGGCGGTAGTTTTCTTCTG
GGCGGTACCGTTCTGGACCGCCAGGACTTCATTGATTTTGGTCTGGAGCTTGTTGACGGC
TGTGAGGCTACCTACAATTCTACTCTGACCAAGATCGGTCCAGACTCGTGGGGCTGGGAC
CCAAAGAAGGTCCCCAGTGACCAGAAAGAATTCTATGAAAAAGCTGGCTTCTATATCAGT
AGTGGTTCGTACGTCCTCCGCCCCGAGGTGATTGAAAGTTTTTACTACGCGCACCGCGTT
ACTGGAAAGGAAATTTACCGTGACTGGGTTTGGAATGCGTTCGTTGCAATTAACTCGACC
TGCCGTACCGACTCTGGTTTCGCTGCTGTATCCGACGTCAACAAGGCGAACGGTGGCTCC
AAGTACGACAACCAAGAGAGTTTCCTCTTCGCCGAGGTCATGAAGTACTCATATCTCGCT
CATTCCGAGGATGCTGCATGGCAAGTCCAGAAGGGTGGCAAGAATACCTTCGTGTACAAC
ACTGAGGCTCACCCGATTAGCGTCGCACGCAACTAA

# Drug_Target_1_General_Function:
Involved in mannosyl-oligosaccharide 1,2-alpha-mannosidase activity

# Drug_Target_1_General_References:
7640307	Yoshida T, Ichishima E: Molecular cloning and nucleotide sequence of the genomic DNA for 1,2-alpha-D-mannosidase gene, msdC from Penicillium citrinum. Biochim Biophys Acta. 1995 Aug 22;1263(2):159-62.
8452520	Yoshida T, Inoue T, Ichishima E: 1,2-alpha-D-mannosidase from Penicillium citrinum: molecular and enzymic properties of two isoenzymes. Biochem J. 1993 Mar 1;290 ( Pt 2):349-54.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3258

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
56570

# Drug_Target_1_Name:
Mannosyl-oligosaccharide alpha-1,2-mannosidase

# Drug_Target_1_Number_of_Residues:
511

# Drug_Target_1_PDB_ID:
1KKT

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01532	Glyco_hydro_47

# Drug_Target_1_Protein_Sequence:
>Mannosyl-oligosaccharide alpha-1,2-mannosidase precursor
MRLPVSFPLTVLSLLGSTIAHPYGETEAVLRSEPKSNQAKADAVKEAFQHAWNGYMKYAF
PHDELTPVSNGHADSRNGWGASAVDALSTAVIMGKADVVNAILEHVADIDFSKTSDTVSL
FETTIRYLAGMLSGYDLLQGPAKNLVDNQDLIDGLLDQSRNLADVLKFAFDTPSGVPYNN
INITSHGNDGATTNGLAVTGTLVLEWTRLSDLTGDEEYAKLSQKAESYLLKPQPSSSEPF
PGLVGSSININDGQFADSRVSWNGGDDSFYEYLIKMYVYDPKRFETYKDRWVLAAESTIK
HLKSHPKSRPDLTFLSSYSNRNYDLSSQHLTCFDGGSFLLGGTVLDRQDFIDFGLELVDG
CEATYNSTLTKIGPDSWGWDPKKVPSDQKEFYEKAGFYISSGSYVLRPEVIESFYYAHRV
TGKEIYRDWVWNAFVAINSTCRTDSGFAAVSDVNKANGGSKYDNQESFLFAEVMKYSYLA
HSEDAAWQVQKGGKNTFVYNTEAHPISVARN

# Drug_Target_1_Reaction:
Hydrolysis of the terminal 1,2-linked alpha-D-mannose residues in the oligo-mannose oligosaccharide Man9(GlcNAc)2 ALL_REAC (other) R05982(G) R06722(G)

# Drug_Target_1_Signals:
1-35

# Drug_Target_1_Specific_Function:
Involved in the maturation of Asn-linked oligosaccharides. Progressively trim alpha-1,2-linked mannose residues from Man(9)GlcNAc(2) to produce Man(5)GlcNAc(2)

# Drug_Target_1_SwissProt_ID:
P31723

# Drug_Target_1_SwissProt_Name:
MAN12_PENCI

# Drug_Target_1_Synonyms:
EC 3.2.1.113
Man(9)-alpha-mannosidase
Mannosyl-oligosaccharide alpha-1,2-mannosidase precursor

# Drug_Target_1_Theoretical_pI:
4.83

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Golgi apparatus membrane

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
MAN2A1

# Drug_Target_2_GenBank_ID_Gene:
D63998

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
MAN2A1

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_2_General_References:
8524845	Misago M, Liao YF, Kudo S, Eto S, Mattei MG, Moremen KW, Fukuda MN: Molecular cloning and expression of cDNAs encoding human alpha-mannosidase II and a previously unrecognized alpha-mannosidase IIx isozyme. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11766-70.

# Drug_Target_2_HGNC_ID:
HGNC:6824

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
5983

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
131142

# Drug_Target_2_Name:
Alpha-mannosidase 2

# Drug_Target_2_Number_of_Residues:
1144

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01074	Glyco_hydro_38
PF07748	Glyco_hydro_38C
PF09261	Alpha-mann_mid

# Drug_Target_2_Protein_Sequence:
>Alpha-mannosidase 2
MKLSRQFTVFGSAIFCVVIFSLYLMLDRGHLDYPRNPRREGSFPQGQLSMLQEKIDHLER
LLAENNEIISNIRDSVINLSESVEDGPKSSQSNFSQGAGSHLLPSQLSLSVDTADCLFAS
QSGSHNSDVQMLDVYSLISFDNPDGGVWKQGFDITYESNEWDTEPLQVFVVPHSHNDPGW
LKTFNDYFRDKTQYIFNNMVLKLKEDSRRKFIWSEISYLSKWWDIIDIQKKDAVKSLIEN
GQLEIVTGGWVMPDEATPHYFALIDQLIEGHQWLENNIGVKPRSGWAIDPFGHSPTMAYL
LNRAGLSHMLIQRVHYAVKKHFALHKTLEFFWRQNWDLGSVTDILCHMMPFYSYDIPHTC
GPDPKICCQFDFKRLPGGRFGCPWGVPPETIHPGNVQSRARMLLDQYRKKSKLFRTKVLL
APLGDDFRYCEYTEWDLQFKNYQQLFDYMNSQSKFKVKIQFGTLSDFFDALDKADETQRD
KGQSMFPVLSGDFFTYADRDDHYWSGYFTSRPFYKRMDRIMESHLRAAEILYYFALRQAH
KYKINKFLSSSLYTALTEARRNLGLFQHHDAITGTAKDWVVVDYGTRLFHSLMVLEKIIG
NSAFLLILKDKLTYDSYSPDTFLEMDLKQKSQDSLPQKNIIRLSAEPRYLVVYNPLEQDR
ISLVSVYVSSPTVQVFSASGKPVEVQVSAVWDTANTISETAYEISFRAHIPPLGLKVYKI
LESASSNSHLADYVLYKNKVEDSGIFTIKNMINTEEGITLENSFVLLRFDQTGLMKQMMT
KEDGKHHEVNVQFSWYGTTIKRDKSGAYLFLPDGNAKPYVYTTPPFVRVTHGRIYSEVTC
FFDHVTHRVRLYHIQGIEGQSVEVSNIVDIRKVYNREIAMKISSDIKSQNRFYTDLNGYQ
IQPRMTLSKLPLQANVYPMTTMAYIQDAKHRLTLLSAQSLGVSSLNSGQIEVIMDRRLMQ
DDNRGLEQGIQDNKITANLFRILLEKRSAVNTEEEKKSVSYPSLLSHITSSLMNHPVIPM
ANKFSSPTLELQGEFSPLQSSLPCDIHLVNLRTIQSKVGNGHSNEAALILHRKGFDCRFS
SKGTGLFCSTTQGKILVQKLLNKFIVESLTPSSLSLMHSPPGTQNISEINLSPMEISTFR
IQLR

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Catalyzes the first committed step in the biosynthesis of complex N-glycans. It controls conversion of high mannose to complex N-glycans; the final hydrolytic step in the N-glycan maturation pathway

# Drug_Target_2_SwissProt_ID:
Q16706

# Drug_Target_2_SwissProt_Name:
MA2A1_HUMAN

# Drug_Target_2_Synonyms:
Alpha-mannosidase II
EC 3.2.1.114
Golgi alpha- mannosidase II
MAN II
Mannosidase alpha class 2A member 1
Mannosyl- oligosaccharide 1,3-1,6-alpha-mannosidase

# Drug_Target_2_Theoretical_pI:
7.61

# Drug_Target_2_Transmembrane_Regions:
6-26

# Drug_Target_3_Cellular_Location:
Endoplasmic reticulum
endoplasmic reticulum membrane
single-pass type II membrane protein

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
MAN1B1

# Drug_Target_3_GenBank_ID_Gene:
AF148509

# Drug_Target_3_GenBank_ID_Protein:
6066222

# Drug_Target_3_GeneCard_ID:
MAN1B1

# Drug_Target_3_Gene_Name:
MAN1B1

# Drug_Target_3_Gene_Sequence:
>2100 bp
ATGGCTGCCTGCGAGGGCAGGAGAAGCGGAGCTCTCGGTTCCTCTCAGTCGGACTTCCTG
ACGCCGCCAGTGGGCGGGGCCCCTTGGGCCGTCGCCACCACTGTAGTCATGTACCCACCG
CCGCCGCCGCCGCCTCATCGGGACTTCATCTCGGTGACGCTGAGCTTTGGCGAGAGCTAT
GACAACAGCAAGAGTTGGCGGCGGCGCTCGTGCTGGAGGAAATGGAAGCAACTGTCGAGA
TTGCAGCGGAATATGATTCTCTTCCTCCTTGCCTTTCTGCTTTTCTGTGGACTCCTCTTC
TACATCAACTTGGCTGACCATTGGAAAGCTCTGGCTTTCAGGCTAGAGGAAGAGCAGAAG
ATGAGGCCAGAAATTGCTGGGTTAAAACCAGCAAATCCACCCGTCTTACCAGCTCCTCAG
AAGGCGGACACCGACCCTGAGAACTTACCTGAGATTTCGTCACAGAAGACACAAAGACAC
ATCCAGCGGGGACCACCTCACCTGCAGATTAGACCCCCAAGCCAAGACCTGAAGGATGGG
ACCCAGGAGGAGGCCACAAAAAGGCAAGAAGCCCCTGTGGATCCCCGCCCGGAAGGAGAT
CCGCAGAGGACAGTCATCAGCTGGAGGGGAGCGGTGATCGAGCCTGAGCAGGGCACCGAG
CTCCCTTCAAGAAGAGCAGAAGTGCCCACCAAGCCTCCCCTGCCACCGGCCAGGACACAG
GGCACACCAGTGCATCTGAACTATCGCCAGAAGGGCGTGATTGACGTCTTCCTGCATGCA
TGGAAAGGATACCGCAAGTTTGCATGGGGCCATGACGAGCTGAAGCCTGTGTCCAGGTCC
TTCAGTGAGTGGTTTGGCCTCGGTCTCACACTGATCGACGCGCTGGACACCATGTGGATC
TTGGGTCTGAGGAAAGAATTTGAGGAAGCCAGGAAGTGGGTGTCGAAGAAGTTACACTTT
GAAAAGGACGTGGACGTCAACCTGTTTGAGAGCACGATCCGCATCCTGGGGGGGCTCCTG
AGTGCCTACCACCTGTCTGGGGACAGCCTCTTCCTGAGGAAAGCTGAGGATTTTGGAAAT
CGGCTAATGCCTGCCTTCAGAACACCATCCAAGATTCCTTACTCGGATGTGAACATCGGT
ACTGGAGTTGCCCACCCGCCACGGTGGACCTCCGACAGCACTGTGGCCGAGGTGACCAGC
ATTCAGCTGGAGTTCCGGGAGCTCTCCCGTCTCACAGGGGATAAGAAGTTTCAGGAGGCA
GTGGAGAAGGTGACACAGCACATCCACGGCCTGTCTGGGAAGAAGGATGGGCTGGTGCCC
ATGTTCATCAATACCCACAGTGGCCTCTTCACCCACCTGGGCGTATTCACGCTGGGCGCC
AGGGCCGACAGCTACTATGAGTACCTGCTGAAGCAGTGGATCCAGGGCGGGAAGCAGGAG
ACACAGCTGCTGGAAGACTACGTGGAAGCCATCGAGGGTGTCAGAACGCACCTGCTGCGG
CACTCCGAGCCCAGTAAGCTCACCTTTGTGGGGGAGCTTGCCCACGGCCGCTTCAGTGCC
AAGATGGACCACCTGGTGTGCTTCCTGCCAGGGACGCTGGCTCTGGGCGTCTACCACGGC
CTGCCCGCCAGCCACATGGAGCTGGCCCAGGAGCTCATGGAGACTTGTTACCAGATGAAC
CGGCAGATGGAGACGGGGCTGAGTCCCGAGATCGTGCACTTCAACCTTTACCCCCAGCCG
GGCCGTCGGGACGTGGAGGTCAAGCCAGCAGACAGGCACAACCTGCTGCGGCCAGAGACC
GTGGAGAGCCTGTTCTACCTGTACCGCGTCACAGGGGACCGCAAATACCAGGACTGGGGC
TGGGAGATTCTGCAGAGCTTCAGCCGATTCACACGGGTCCCCTCGGGTGGCTATTCTTCC
ATCAACAATGTCCAGGATCCTCAGAAGCCCGAGCCTAGGGACAAGATGGAGAGCTTCTTC
CTGGGGGAGACGCTCAAGTATCTGTTCTTGCTCTTCTCCGATGACCCAAACCTGCTCAGC
CTGGACGCCTACGTGTTCAACACCGAAGCCCACCCTCTGCCTATCTGGACCCCTGCCTAG

# Drug_Target_3_General_Function:
Involved in mannosyl-oligosaccharide 1,2-alpha-mannosidase activity

# Drug_Target_3_General_References:
10409699	Gonzalez DS, Karaveg K, Vandersall-Nairn AS, Lal A, Moremen KW: Identification, expression, and characterization of a cDNA encoding human endoplasmic reticulum mannosidase I, the enzyme that catalyzes the first mannose trimming step in mammalian Asn-linked oligosaccharide biosynthesis. J Biol Chem. 1999 Jul 23;274(30):21375-86.
10521544	Tremblay LO, Herscovics A: Cloning and expression of a specific human alpha 1,2-mannosidase that trims Man9GlcNAc2 to Man8GlcNAc2 isomer B during N-glycan biosynthesis. Glycobiology. 1999 Oct;9(10):1073-8.
12975309	Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C, Currell B, Deuel B, Dowd P, Eaton D, Foster J, Grimaldi C, Gu Q, Hass PE, Heldens S, Huang A, Kim HS, Klimowski L, Jin Y, Johnson S, Lee J, Lewis L, Liao D, Mark M, Robbie E, Sanchez C, Schoenfeld J, Seshagiri S, Simmons L, Singh J, Smith V, Stinson J, Vagts A, Vandlen R, Watanabe C, Wieand D, Woods K, Xie MH, Yansura D, Yi S, Yu G, Yuan J, Zhang M, Zhang Z, Goddard A, Wood WI, Godowski P, Gray A: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003 Oct;13(10):2265-70. Epub 2003 Sep 15.

# Drug_Target_3_HGNC_ID:
HGNC:6823

# Drug_Target_3_HPRD_ID:
05068

# Drug_Target_3_ID:
2577

# Drug_Target_3_Locus:
9q34

# Drug_Target_3_Molecular_Weight:
79581

# Drug_Target_3_Name:
Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase

# Drug_Target_3_Number_of_Residues:
699

# Drug_Target_3_PDB_ID:
1X9D

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF01532	Glyco_hydro_47

# Drug_Target_3_Protein_Sequence:
>Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase
MAACEGRRSGALGSSQSDFLTPPVGGAPWAVATTVVMYPPPPPPPHRDFISVTLSFGENY
DNSKSWRRRSCWRKWKQLSRLQRNMILFLLAFLLFCGLLFYINLADHWKALAFRLEEEQK
MRPEIAGLKPANPPVLPAPQKADTDPENLPEISSQKTQRHIQRGPPHLQIRPPSQDLKDG
TQEEATKRQEAPVDPRPEGDPQRTVISWRGAVIEPEQGTELPSRRAEVPTKPPLPPARTQ
GTPVHLNYRQKGVIDVFLHAWKGYRKFAWGHDELKPVSRSFSEWFGLGLTLIDALDTMWI
LGLRKEFEEARKWVSKKLHFEKDVDVNLFESTIRILGGLLSAYHLSGDSLFLRKAEDFGN
RLMPAFRTPSKIPYSDVNIGTGVAHPPRWTSDSTVAEVTSIQLEFRELSRLTGDKKFQEA
VEKVTQHIHGLSGKKDGLVPMFINTHSGLFTHLGVFTLGARADSYYEYLLKQWIQGGKQE
TQLLEDYVEAIEGVRTHLLRHSEPSKLTFVGELAHGRFSAKMDHLVCFLPGTLALGVYHG
LPASHMELAQELMETCYQMNRQMETGLSPEIVHFNLYPQPGRRDVEVKPADRHNLLRPET
VESLFYLYRVTGDRKYQDWGWEILQSFSRFTRVPSGGYSSINNVQDPQKPEPRDKMESFF
LGETLKYLFLLFSDDPNLLSLDAYVFNTEAHPLPIWTPA

# Drug_Target_3_Reaction:
Hydrolysis of the terminal 1,2-linked alpha-D-mannose residues in the oligo-mannose oligosaccharide Man9(GlcNAc)2 ALL_REAC (other) R05982(G) R06722(G)

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Involved in the maturation of Asn-linked oligosaccharides. Trim a single alpha-1,2-linked mannose residue from Man(9)GlcNAc(2) to produce Man(8)GlcNAc(2). The only product is the Man(8)GlcNAc(2) isomer B, the form lacking the middle-arm terminal alpha 1,2-mannose. It may be involved in glycoprotein quality control since it is important to target misfolded glycoproteins for degradation

# Drug_Target_3_SwissProt_ID:
Q9UKM7

# Drug_Target_3_SwissProt_Name:
MA1B1_HUMAN

# Drug_Target_3_Synonyms:
EC 3.2.1.113
ER alpha-1,2-mannosidase
Man9GlcNAc2-specific-processing alpha-mannosidase
Mannosidase alpha class 1B member 1

# Drug_Target_3_Theoretical_pI:
7.80

# Drug_Target_3_Transmembrane_Regions:
85-105

#END_DRUGCARD DB02742
